Pharmacokinetics of Opioids in Liver Disease

By Tegeder I.   Lötsch J.   Geisslinger G.  

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 17-40

Adis International

Access to resources Recommend Favorite

Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids

By Valverde O.   Fournie-Zaluski M.-C.   Roques B.P.   Maldonado R.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 15-25

Elsevier

Access to resources Recommend Favorite

Effects of Liver Disease on Pharmacokinetics: An Update

By Rodighiero V.  

Clinical Pharmacokinetics, Vol. 37, Iss. 5, 1999-11 ,pp. : 399-431

Adis International

Access to resources Recommend Favorite

The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist

By Lieberman P.B.   Woods J.H.   Young E.A.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids

By Campbell V.C.   Welch S.P.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 91-98

Elsevier

Access to resources Recommend Favorite